Terveystalo Oy Class A TTALO

OMXHEX · Finland · Health Services

€7.440.00 (0.00%)

Market closed· Oct 1, 2026, 3:29 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Terveystalo Oy Class A TTALO

OMXHEX · Finland · Health Services

€7.440.00 (0.00%)

Market closed· Oct 1, 2026, 3:29 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-14.58% · 6MFull-screen chart

Open €7.51High €7.52Low €7.44Close €7.44Volume 198.20K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €7.44
Day range: €7.44 – €7.52
52-week range: €6.45 – €10.42
Volume: 198.20K
Market cap: €939.72M
P/E (TTM): 14.0
Dividend yield (annualized): 7.53%
Next earnings date: 2026-10-21
Avg. volume (1Y): 197.85K

Performance

1 week

-1.06%

1 month

-3.61%

3 months

-3.36%

6 months

-13.04%

Year to date

-19.54%

1 year

-21.41%

Total return, dividends included.

Company profile

Sector: Health Services
Industry: Medical/Nursing Services
Country: Finland
Exchange: OMXHEX
Shares outstanding: 126.81M
Employees: 8,356
ISIN: FI4000252127
Beta: 0.17

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceApr 14, 2026

How The Terveystalo (HLSE:TTALO) Story Is Shifting After The Analyst Downgrade

The shift in Terveystalo Oyj’s analyst stance comes with a recalibrated price target at €10.70 and a fair value estimate trimmed from €11.28 to €11.10. Analysts have moved the rating to Hold, signalling more caution around how quickly the story might play out, even though the fair value still sits slightly above the new target. Read on to see what this means for you and how to keep track of the evolving narrative around the shares. Stay updated as the Fair Value for Terveystalo Oyj shifts by...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.